We are live on ! Find out more
DU

Delphia (USA) Portfolio holdings

AUM $445K
1-Year Est. Return 28.82%
This Fund
S&P 500
This Quarter Est. Return
-16.08%
1 Year Est. Return
+28.82%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$145M
AUM Growth
+$11.8M
Cap. Flow
+$38.6M
Cap. Flow %
26.54%
Top 10 Hldgs %
11.34%
Holding
533
New
208
Increased
130
Reduced
42
Closed
153

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$1.1M
2
MA icon
Mastercard
MA
+$1.06M
3
DK icon
Delek US
DK
+$978K
4
RIVN icon
Rivian
RIVN
+$977K
5
LNG icon
Cheniere Energy
LNG
+$955K

Top Sells

Rank Stock Value
1
OXY icon
Occidental Petroleum
OXY
+$1.16M
2
PSX icon
Phillips 66
PSX
+$1.09M
3
APA icon
APA Corp
APA
+$1.02M
4
EQT icon
EQT Corp
EQT
+$961K
5
VST icon
Vistra
VST
+$842K

Sector Composition

Rank Sector Weight
1 Technology 19.22%
2 Healthcare 18.31%
3 Consumer Discretionary 13.71%
4 Industrials 8.71%
5 Financials 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMB icon
251
Williams Companies
WMB
$87.8B
$226K 0.16%
+7,241
New +$250K
LSEA
252
DELISTED
Landsea Homes
LSEA
$225K 0.15%
+33,820
New +$264K
SPG icon
253
Simon Property Group
SPG
$71.9B
$225K 0.15%
+2,371
New +$272K
ABBV icon
254
AbbVie
ABBV
$431B
$224K 0.15%
+1,460
New +$223K
SLAB icon
255
Silicon Laboratories
SLAB
$7.21B
$222K 0.15%
+1,585
New +$222K
BZH icon
256
Beazer Homes USA
BZH
$915M
$221K 0.15%
+18,302
New +$268K
WE
257
DELISTED
WeWork Inc.
WE
$220K 0.15%
+1,098
New +$283K
ARWR icon
258
Arrowhead Research
ARWR
$12.1B
$219K 0.15%
+6,219
New +$234K
NTLA icon
259
Intellia Therapeutics
NTLA
$1.57B
$219K 0.15%
+4,238
New +$215K
NFE icon
260
New Fortress Energy
NFE
$98M
$218K 0.15%
+5,501
New +$237K
BND icon
261
Vanguard Total Bond Market
BND
$157B
$216K 0.15%
+2,870
New +$218K
TWTR
262
DELISTED
Twitter, Inc.
TWTR
$216K 0.15%
+5,769
New +$247K
SM icon
263
SM Energy
SM
$6.88B
$215K 0.15%
6,289
-4,394
-41% -$179K
CVCO icon
264
Cavco Industries
CVCO
$4.45B
$213K 0.15%
+1,085
New +$242K
ETSY icon
265
Etsy
ETSY
$7.81B
$213K 0.15%
+2,913
New +$266K
VEEV icon
266
Veeva Systems
VEEV
$35.4B
$212K 0.15%
1,072
-1,541
-59% -$284K
M icon
267
Macy's
M
$6.61B
$211K 0.15%
11,500
-28,925
-72% -$654K
KURA icon
268
Kura Oncology
KURA
$824M
$210K 0.14%
+11,430
New +$164K
PCAR icon
269
PACCAR
PCAR
$69.5B
$209K 0.14%
+3,812
New +$215K
CPE
270
DELISTED
Callon Petroleum Company
CPE
$209K 0.14%
+5,336
New +$286K
NTRA icon
271
Natera
NTRA
$38B
$208K 0.14%
+5,880
New +$218K
NKLA
272
DELISTED
Nikola Corporation Common Stock
NKLA
$207K 0.14%
1,447
+133
+10% +$27.2K
BMRN icon
273
BioMarin Pharmaceuticals
BMRN
$11.9B
$206K 0.14%
+2,486
New +$198K
CAL icon
274
Caleres
CAL
$486M
$206K 0.14%
+7,861
New +$195K
ELS icon
275
Equity Lifestyle Properties
ELS
$12.5B
$206K 0.14%
2,928
+270
+10% +$20.1K

Similar funds

Delphia (USA)'s Q2 2022 Portfolio in Review

As of Q2 2022, Delphia (USA) held 533 positions worth $145M, up 8.9% from $134M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Delphia (USA) deployed $38.6M of net new capital in Q2 2022, opening 208 new positions and adding to 130 existing holdings. Its largest new stake was McDonald's: 4,462 shares worth $1.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Occidental Petroleum, an estimated $1.16M trimmed.

  • Delphia (USA)'s largest Q2 2022 buy was McDonald's: 4,462 shares worth $1.1M.
  • Delphia (USA) added most to Mastercard in Q2 2022, an estimated $1.06M increase.
  • Delphia (USA)'s biggest Q2 2022 reduction was Occidental Petroleum, cutting an estimated $1.16M.
  • Delphia (USA) fully exited Phillips 66 in Q2 2022, selling an estimated $1.09M.
  • Delphia (USA)'s ten largest holdings make up 11% of its $145M portfolio in Q2 2022.
  • Delphia (USA) opened 208 new positions and closed 153 in Q2 2022.
  • Delphia (USA)'s portfolio value rose 8.9% quarter-over-quarter to $145M.

Based on Delphia (USA)'s 13F filing for Q2 2022, filed 15 Aug 2022.